Hence, we conducted a more detailed analysis to determine the impact of TRIM26 overexpression or knockdown on the mTOR signaling pathway in ccRCC by examining the phosphorylation levels of upstream kinase AKT and key mTOR pathway components such as p-mTOR and p-4EBP1. Here, AKT1 is linked to nonpapillary renal cell carcinoma.